Press releases

DEINOVE immediately strengthens its cash position by €1 million DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses...

For the second year in a row, DEINOVE has called on Société Générale Factoring (SGF) to pre-finance its R&D Tax Credit receivable...

The current health, economic and financial crisis creates too much uncertainty to enter into a long-term full partnership around a complete...

The 2019 financial results are postponed to April 29, 2020. At this stage, the other dates remain unchanged. DEINOVE (Euronext Growth Paris...

BIOME Oléoactif® is an exclusive active ingredient that regulates skin microbiota and reinforces skin barrier function, thanks to a unique...

The AGIR program, supported by the French Investments for the Future program, aims to accelerate new antibiotics discovery to tackle the...

Its second innovative carotenoid has the particularity of absorbing blue light, which is responsible for premature skin ageing, the...

The signed Memorandum of Understanding (MoU) covers the development and marketing of an exclusive range of bio-based ingredients for...

The Phase II clinical trial aims to evaluate the efficacy, safety and pharmacokinetics of DNV3837 in patients with Clostridioides difficile...

DEINOVE launches the production of a new batch of Phyt-N-Resist® to meet the needs of its distributors and future customers. Several...